Biogen: Competing With Eli Lilly's Kisunla, Safety Gives Market Edge

Discover why Biogen Inc.'s stock surged 15% in 2025, driven by Skyclarys sales. Explore its strong growth potential and ...
pharmaphorum

Whistleblower gets $250m as Biogen settles US kickbacks case

Biogen has finalised a $900 million payment to settle a whistleblower lawsuit claiming that it paid kickbacks to US doctors to prescribe its multiple sclerosis drugs. According to a Department of ...
pharmaphorum

First Tysabri biosimilar cleared by FDA for MS

Sandoz and Polpharma Biologics have become the first companies to get FDA approval for a biosimilar of Biogen's blockbuster multiple sclerosis therapy Tysabri, after overcoming a bid by Biogen to ...
Everyday Health

Can You Take Folic Acid and Iron at the Same Time?

Your red blood cells need iron and folic acid to function properly. If you don't get enough iron or folic acid from your diet, you can take supplements. You can find supplements that combine folic ...
National Institute for Health and Care Excellence

Topic prioritisation

Doravirine–islatravir for treating HIV-1 in people with virological suppression on antiretroviral therapy [TSID12173] None selected Not selected 10 April 2025 Doravirine–islatravir for treating HIV-1 ...
C&EN

Dimethyl Sulfoxide Involved One-Pot Synthesis of Quinoxaline Derivatives

† Key Laboratory of Special Functional Aggregated Materials, Ministry of Education, School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P. R. China ‡ State Key Laboratory ...